At the @uksbcoa.bsky.social, David Fardoโs research is driving breakthroughs in understanding dementia. His goal is to find answers for Kentucky families. 
Learn how NIH funding is crucial to that mission: research.uky.edu/news/researc...
@neurosciencerpa.bsky.social
The guiding strategy of the University of Kentucky Neuroscience Research Priority Area (NRPA) is to provide broad-based support to neuroscience researchers across the university.
At the @uksbcoa.bsky.social, David Fardoโs research is driving breakthroughs in understanding dementia. His goal is to find answers for Kentucky families. 
Learn how NIH funding is crucial to that mission: research.uky.edu/news/researc...
UKโs research โtrifectaโ of NIH-funded centers โ Sanders-Brown Center on Aging, CCTS and Markey Cancer Center โ drive breakthroughs in aging, translational science and cancer research.
Learn more: research.uky.edu/news/how-nih...
Research that transforms brain health is the goal of @uksbcoa.bsky.social.
Dr. Linda Van Eldik explains how NIH funding is crucial to advancing this important work. 
Learn more: research.uky.edu/news/researc...
Keeping golden years golden โ Dr. Greg Jicha at UK's Sanders-Brown Center on Aging is leading research to combat Alzheimerโs and dementia in Kentucky. Discover how NIH funding makes that possible.
Learn more: www.research.uky.edu/news/researc...
Research drives discovery at UK.
Funding from the NIH makes a difference. UK Acting Vice President for Research Ilhem Messaoudi explains how this funding impacts Kentuckians.
Learn more: www.research.uky.edu/news/researc...
Darlingtina K. Esiaka, Ph.D., an assistant professor in the Department of Behavioral Science in the University of Kentucky College of Medicine
Darlingtina K. Esiaka, a researcher with the UK College of Medicine, has been awarded a fellowship to travel to Nigeria and work with the Research Center for Ageing Cognition and Psychological Health at Nnamdi Azikiwe University.
Learn more: www.research.uky.edu/news/uk-rese...
The ๐๐๐ญ๐ก ๐๐ง๐ง๐ฎ๐๐ฅ ๐๐ข๐ง๐ ๐๐๐ญ๐ญ๐๐ซ๐ฌ ๐๐๐๐ฅ๐ญ๐ก ๐ ๐๐ข๐ซ is approaching! We hope you will join us! @neurosciencerpa.bsky.social @ukresearch.bsky.social
08.04.2025 17:42 โ ๐ 2 ๐ 2 ๐ฌ 0 ๐ 0We were thrilled to share the importance of new therapies for Alzheimer's! Thank you @istaart.bsky.social
04.04.2025 12:58 โ ๐ 3 ๐ 2 ๐ฌ 0 ๐ 0Kudos to ๐๐๐ง ๐๐ฅ๐๐ข๐ค lab members ๐๐๐ฅ๐๐ ๐๐๐ข๐ฅ๐๐ฒ & ๐๐๐๐๐ง๐ง๐ ๐๐ซ๐๐๐ง as they share their research at #ADPD2025!
#cytokines #p38a
A great write up on our recent work in PNAS attempting to understand metabolic drivers of sleep, led by @ncons95.bsky.social !
uknow.uky.edu/research/fue...
"Thanks to innovative research at the University of Kentucky, [Billy] Kennedy has not only maintained a high quality of life but has also played a crucial role in shaping the future of Parkinsonโs treatment."
uknow.uky.edu/uk-healthcar...
Julie Pendergast (@juliepclocks.bsky.social) uncovers hidden health effects of disrupted sleep, circadian rhythms
uknow.uky.edu/research/jul...
Andrew Stewart, Ph.D.
Researchers uncover hidden barrier to spinal cord injury recovery.
Andrew Stewart, with the UK College of Medicine, is investigating why treatments that could help repair and regenerate the damaged spinal cord stop working shortly after the injury.
Learn more: www.research.uky.edu/news/uk-rese...
New therapeutic targets for Alzheimer's (AD)? Work by @bah-ioinformatics.bsky.social, ๐๐๐ซ๐ค ๐๐๐๐๐ซ๐ญ, ๐๐ก๐, ๐๐๐ฏ๐ข๐ ๐
๐๐ซ๐๐จ, ๐๐ก๐ & collaborators suggest new possibilities! @neurosciencerpa.bsky.social @alzdemjournals.bsky.social 
alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
Rare Disease Day spotlight: A new approach to studying Moyamoya syndrome
uknow.uky.edu/research/rar...
Last week, @morganti.bsky.social provided an insightful talk about microglia during our monthly Seminar Series. In case you didn't know, we've got some amazing scientists at Sanders-Brown! @neurosciencerpa.bsky.social
28.02.2025 13:44 โ ๐ 3 ๐ 2 ๐ฌ 0 ๐ 1๐ฃ SAVE THE DATE! ๐ฃ
The 2025 Neuroscience Clinical-Translational Research Symposium will be on November 6-7th!